Last updated on May 6th, 2021 at 08:01 am
President Rodrigo Duterte has signed an executive order imposing a maximum retail price for certain products, a top official from Malacañang said Monday.
Executive Secretary Salvador Medialdea said Duterte had signed EO 104, which aims to improve access to affordable medicines for the Filipinos.
A copy of the EO has yet to be released by The Palace.
Later the Department of Health (DOH) said its price regulation plan covered drugs for hypertension, diabetes, cardiovascular disease, chronic lung diseases, neonatal diseases and major cancers, high-cost therapies for chronic renal disease, psoriasis, and rheumatoid arthritis.
Rates of selected medicines are projected to have an average 56 percent decrease from prevailing market rates once the EO comes into effect, the DOH said in September last year.
The Philippine Pharmaceutical and Healthcare Association had opposed the measure, arguing that price regulation will kill the country’s small retailers and force manufacturers to reconsider the launch of new drugs.
A Market Catching Its Breath The Singapore market turned noticeably quieter after the Straits Times Index (STI) went down, reflecting…
In response to a sudden and highly visible spike in strategic naval operations, the attention of the world has been…
The fast naval build-up in the area of Taiwan and Japan is causing the tension of East Asia to be…
The future of Asia in 2026 has an excellent combination of both opportunities and risks: a fresh wave of IPO…
On a dining table, food from many different cultures may look the same, but that is not the case. After…
Asia Power Index 2025 reveals a significant change of the region of Asia, transforming the entire continent. While the struggle…
This website uses cookies.
Read More